Agilux: Agilux Laboratories Appoints Dr. Richard LeLacheur as Head of GLP Bioanalysis

WORCESTER, Mass.--(BUSINESS WIRE)--Agilux Laboratories, a leading provider of Drug Metabolism and Pharmacokinetics (DMPK) services to pharmaceutical and biotechnology firms, announced today that it has appointed Richard M. LeLacheur, Ph.D. to Head of GLP Bioanalysis for its pharmaceutical development services. Rich joined Agilux in early 2012 as Senior Director, Bioanalytical Operations and has also served as a member of its senior management team since that time.